In addition, some small molecule compounds, especially some natural compounds, targeting sirt1 may also serve as potentially promising candidates for the treatment of kidney diseases, like RSV, Catalpol and Astragaloside IV. The gene discussed is SIRT1; the disease is kidney disorder.